--- title: "LoD / LoQ Definition & Meaning | MedTech Terms" description: "Lowest analyte concentrations an assay can reliably detect (LoD) or quantify (LoQ). Plain-English Clinical & Trials definition for MedTech teams, with examples" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/lod-loq#term", "name": "Limit of Detection / Limit of Quantitation", "alternateName": "LoD / LoQ", "description": "LoD is the lowest concentration distinguishable from a blank with stated probability. LoQ is the lowest concentration that can be quantitatively measured with stated accuracy and precision (per CLSI EP17 / EP05).", "url": "https://medtechterms.com/terms/lod-loq", "termCode": "lod-loq", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/lod-loq#article", "headline": "LoD / LoQ, Limit of Detection / Limit of Quantitation", "description": "Lowest analyte concentrations an assay can reliably detect (LoD) or quantify (LoQ).", "url": "https://medtechterms.com/terms/lod-loq", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/lod-loq" }, "about": { "@id": "https://medtechterms.com/terms/lod-loq#term" }, "articleSection": "Clinical & Trials", "inLanguage": "en", "keywords": "Limit of Detection / Limit of Quantitation, LoD / LoQ, Clinical & Trials, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "CLSI EP17", "url": "https://clsi.org/standards/products/method-evaluation/documents/ep17/", "publisher": { "@type": "Organization", "name": "CLSI" } }, { "@type": "CreativeWork", "name": "ISO 14155 Standard Page", "url": "https://www.iso.org/standard/71690.html", "publisher": { "@type": "Organization", "name": "ISO" } }, { "@type": "CreativeWork", "name": "FDA - Clinical Trials and Human Subject Protection", "url": "https://www.fda.gov/science-research/science-and-research-special-topics/clinical-trials-and-human-subject-protection", "publisher": { "@type": "Organization", "name": "FDA" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/analytical-sensitivity#term", "name": "Analytical Sensitivity", "url": "https://medtechterms.com/terms/analytical-sensitivity" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/ivdr#term", "name": "EU In Vitro Diagnostic Regulation", "alternateName": "IVDR", "url": "https://medtechterms.com/terms/ivdr" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Clinical & Trials", "item": "https://medtechterms.com/terms?cat=Clinical%20%26%20Trials" }, { "@type": "ListItem", "position": 4, "name": "Limit of Detection / Limit of Quantitation", "item": "https://medtechterms.com/terms/lod-loq" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/lod-loq#faq", "mainEntity": [ { "@type": "Question", "name": "Why are LoD and LoQ important for IVDs?", "acceptedAnswer": { "@type": "Answer", "text": "LoD and LoQ demonstrate an IVD's analytical sensitivity, ensuring it can reliably detect and measure analytes at low concentrations, which is critical for accurate diagnosis and patient management, especially in early disease detection or monitoring of minimal residual disease." } }, { "@type": "Question", "name": "How do LoD and LoQ differ?", "acceptedAnswer": { "@type": "Answer", "text": "LoD is the lowest concentration at which an analyte can be reliably detected, meaning distinguished from its absence. LoQ is the lowest concentration at which an analyte can be not only detected but also measured with a specified level of accuracy and precision." } }, { "@type": "Question", "name": "What standards guide LoD/LoQ determination?", "acceptedAnswer": { "@type": "Answer", "text": "The Clinical and Laboratory Standards Institute (CLSI) provides specific guidance for determining LoD and LoQ, notably in documents such as EP17, Measurement of Low Analyte Concentrations by Clinical Laboratory Devices, and EP05, Evaluation of Precision of Quantitative Measurement Procedures." } }, { "@type": "Question", "name": "Can LoD and LoQ change over time?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, LoD and LoQ may need re-evaluation if there are significant changes to the IVD's reagents, manufacturing process, or instrumentation that could impact its analytical performance. Regular monitoring and validation studies are good practice." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Clinical & Trials](/terms?cat=Clinical%20%26%20Trials) 6. / 7. Limit of Detection / Limit of Quantitation [All terms](/terms) Clinical & Trials [Clinical Evidence](/ecosystems/clinical-evidence)LoD / LoQ # Limit of Detection / Limit of Quantitation Lowest analyte concentrations an assay can reliably detect (LoD) or quantify (LoQ). Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition LoD is the lowest concentration distinguishable from a blank with stated probability. LoQ is the lowest concentration that can be quantitatively measured with stated accuracy and precision (per CLSI EP17 / EP05). What the regulation says Regulatory bodies like the FDA and organizations such as the Clinical and Laboratory Standards Institute (CLSI) require the establishment of Limits of Detection (LoD) and Quantitation (LoQ) for in vitro diagnostic ( [IVD](/terms/ivd)) devices. These analytical performance characteristics, as described in documents like CLSI EP17 and EP05, are crucial for validating the claims of an IVD, particularly for assays where the detection and measurement of low analyte concentrations are clinically significant, such as in infectious diseases or oncology. Manufacturers must demonstrate that their assays can reliably detect and quantify analytes at these lower limits to ensure patient safety and effective treatment decisions, aligning with requirements in 21 CFR Part 809 for IVDs and principles seen in EU [IVDR](/terms/ivdr) Annex I, [General Safety and Performance Requirements](/terms/gspr). ## What this means in practice Critical performance characteristics for [IVD](/terms/ivd) claims, especially for infectious disease and oncology assays where low-burden detection drives clinical utility. ## Examples - An IVD manufacturer determines the LoD for its new HIV viral load assay to ensure it can detect very low levels of viral RNA in early infection, as required by FDA guidance. - A molecular diagnostic company establishes the LoQ for its oncology assay to precisely measure circulating tumor DNA fragments, guiding treatment selection and monitoring in cancer patients. - An assay for detecting bacterial pathogens in blood culture is validated with an LoD study to confirm its ability to identify low colony counts before clinical symptoms become severe. Common pitfalls - • Failing to establish LoD and LoQ using appropriate statistical methods can lead to invalid claims regarding assay sensitivity. - • Not re-evaluating LoD and LoQ after significant assay modifications can result in underperforming or non-compliant devices. - • Confusing LoD with clinical sensitivity can lead to misinterpretation of an assay's true diagnostic capability. - • Using inappropriate sample matrices for LoD and LoQ studies can invalidate the relevance of the established limits to real-world clinical use. - • Presenting a single LoD or LoQ value when different matrices or sample types require distinct limits is a common oversight. ## Frequently asked questions Why are LoD and LoQ important for IVDs? LoD and LoQ demonstrate an [IVD](/terms/ivd)'s [analytical sensitivity](/terms/analytical-sensitivity), ensuring it can reliably detect and measure analytes at low concentrations, which is critical for accurate diagnosis and patient management, especially in early disease detection or monitoring of minimal residual disease. How do LoD and LoQ differ? What standards guide LoD/LoQ determination? Can LoD and LoQ change over time? ## Cross-references ### See also Closely related context worth reading. - [ Analytical Sensitivity ](/terms/analytical-sensitivity) ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Clinical & Trials Analytical Sensitivity An IVD's ability to detect small quantities of an analyte. ](/terms/analytical-sensitivity)[ Regulatory EU In Vitro Diagnostic Regulation(IVDR) Regulation (EU) 2017/746 governing in vitro diagnostic medical devices in the EU. ](/terms/ivdr) ### More in Clinical & Trials · Same category [ Clinical & Trials Adaptive Trial Design Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data. ](/terms/adaptive-trial)[ Clinical & Trials Adverse Event(AE) Any untoward medical occurrence in a subject, whether or not related to the device. ](/terms/adverse-event)[ Clinical & Trials ALCOA+ Data integrity principles: Attributable, Legible, Contemporaneous, Original, Accurate (plus Complete, Consistent, Enduring, Available). ](/terms/alcoa-plus)[ Clinical & Trials Bayesian Trial Design Trial design that uses Bayesian statistics, often incorporating prior data from related studies or registries. ](/terms/bayesian-trial) Cited by Where this term appears across MedTech Terms. Ecosystems (1) - [Clinical Evidence](/ecosystems/clinical-evidence) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 CLSI· 1 ISO· 1 FDA· 1 1. [1 CLSI EP17 Verified CLSI · clsi.org ](https://clsi.org/standards/products/method-evaluation/documents/ep17/) 2. [2 ISO 14155 Standard Page Verified ISO · iso.org ](https://www.iso.org/standard/71690.html) 3. [3 FDA - Clinical Trials and Human Subject Protection Verified FDA · fda.gov ](https://www.fda.gov/science-research/science-and-research-special-topics/clinical-trials-and-human-subject-protection) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Clinical evidence intersecting with device security? We support clinical-stage MedTech teams whose investigational devices touch patient data or hospital networks. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Clinical & Trials Acronym LoD / LoQ Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=lod-loq) Learn in 60 seconds Card Lesson Quiz Lowest analyte concentrations an assay can reliably detect (LoD) or quantify (LoQ). - · Critical performance characteristics for IVD claims, especially for infectious disease and oncology assays where low-burden detection drives clinical utility. - · LoQ is the lowest concentration that can be quantitatively measured with stated accuracy and precision (per CLSI EP17 / EP05). Remember this Watch out: Failing to establish LoD and LoQ using appropriate statistical methods can lead to invalid claims regarding assay sensitivity. Related terms - [Analytical Sensitivity ](/terms/analytical-sensitivity) - [EU In Vitro Diagnostic Regulation(IVDR) ](/terms/ivdr) You may also need Auto-suggested from Clinical & Trials and shared keywords. - [Analytical Performance (IVDR) ](/terms/ivdr-analytical-performance) - [Propensity Score Methods ](/terms/propensity-score) - [Sample Size and Statistical Power ](/terms/sample-size-power) - [AI Imaging Software ](/terms/ai-imaging) [All Clinical & Trials terms](/terms?cat=Clinical%20%26%20Trials) From the Blue Goat network Related resources and services on this topic. - [ MedTech Launchpad MedTech funding rounds, accelerators, and launch resources. ](https://medtechlaunchguide.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)